US00430H2013 - Common Stock
ACCELERATE DIAGNOSTICS INC
NASDAQ:AXDX (5/3/2024, 7:00:01 PM)
After market: 0.98 +0.06 (+5.97%)0.9248
-0.02 (-1.82%)
Accelerate Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Denver, Colorado and currently employs 179 full-time employees. Accelerate Diagnostics, Inc. is an in-vitro diagnostics company. The firm is engaged in providing solutions that improve patient outcomes through the diagnosis of serious infections. Its in-vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The company detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk.
ACCELERATE DIAGNOSTICS INC
3950 S Country Club Rd Ste 470 Bldg 3-307
Denver COLORADO 85714
P: 13038638088
CEO: Jack Phillips
Employees: 179
Website: http://acceleratediagnostics.com/
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m....
AXDX stock results show that Accelerate Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Accelerate Diagnostics (NASDAQ:AXDX) just reported results for the fourth quart...
/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023. "In...
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30...
Accelerate Diagnostics (NASDAQ:AXDX) said Friday it priced an underwritten public offering of units and a concurrent private placement to raise up to $15...
Here you can normally see the latest stock twits on AXDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: